{"name":"Mendel Tuchman","slug":"mendel-tuchman","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":200000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Carbaglu","genericName":"Carbaglu","slug":"carbaglu","revenue":200000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":200000000,"percentOfTotal":100,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Carbaglu","genericName":"Carbaglu","slug":"carbaglu","indication":"Hyperammonemia associated with N-acetylglutamate synthase deficiency","status":"marketed","revenue":200000000}]}],"pipeline":[{"name":"Carbaglu","genericName":"Carbaglu","slug":"carbaglu","phase":"marketed","mechanism":"Carbamoyl-phosphate synthase [ammonia], mitochondrial","indications":["Hyperammonemia associated with N-acetylglutamate synthase deficiency"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}